CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $343,325,294
- in 74 filings, $342.5M under 10b5-1 plans
Net −$343,325,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-13 | BENKOWITZ MICHAEL PRESIDENT AND COO | Gift · Stock Option | −11,728 | 0 | ||
| 2026-05-13 | BENKOWITZ MICHAEL PRESIDENT AND COO | Gift · Stock Option | +11,728 | 99,720 | ||
| 2026-03-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion | +17,790 | 17,790 | ||
| 2026-03-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion | +15,592 | 33,752 | ||
| 2026-03-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Shares withheld for taxes | −7,837 | $536.12 | $4.2M | 25,915 |
| 2026-03-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Shares withheld for taxes | −6,869 | $536.12 | $3.7M | 19,046 |
| 2026-03-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Restricted Stock Units | −17,790 | 0 | ||
| 2026-03-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Restricted Stock Units | −15,592 | 0 | ||
| 2026-02-23 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +9,375 | $117.76 | $1.1M | 9,375 |
| 2026-02-23 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −9,375 | $472.13 | $4.4M | 0 |
| 2026-02-23 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +5,065 | $146.03 | $740K | 5,065 |
| 2026-02-23 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −5,065 | $472.13 | $2.4M | 0 |
| 2026-02-23 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Common Stock 10b5-1 | −9,375 | 0 | ||
| 2026-02-23 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Common Stock 10b5-1 | −5,065 | 0 | ||
| 2026-02-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $117.76 | $1.7M | 14,625 |
| 2026-02-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −14,625 | $480.75 | $7.0M | 0 |
| 2026-02-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2026-02-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $480.75 | $3.8M | 0 |
| 2026-02-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Common Stock 10b5-1 | −14,625 | 9,375 | ||
| 2026-02-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Common Stock 10b5-1 | −7,875 | 5,065 |
Page 1 of 35 · 699 trades